SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062204
Filing Date
2023-11-09
Accepted
2023-11-09 17:00:31
Documents
49
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20230930.htm   iXBRL 10-Q 2073112
2 EX-31.1 tcon-ex31_1.htm EX-31.1 12412
3 EX-31.2 tcon-ex31_2.htm EX-31.2 12056
4 EX-32.1 tcon-ex32_1.htm EX-32.1 8294
5 EX-32.2 tcon-ex32_2.htm EX-32.2 7978
  Complete submission text file 0000950170-23-062204.txt   6781320

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230930_pre.xml EX-101.PRE 244627
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcon-20230930_def.xml EX-101.DEF 148321
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230930_lab.xml EX-101.LAB 342081
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230930.xsd EX-101.SCH 49027
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcon-20230930_cal.xml EX-101.CAL 29889
43 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230930_htm.xml XML 1102795
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 231393544
SIC: 2836 Biological Products, (No Diagnostic Substances)